biguanides has been researched along with Demyelinating Diseases in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0." | 5.39 | Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. ( Aminian, A; Dehpour, AR; Ghazi-Khansari, M; Hassanzadeh, G; Javadi, S; Kafami, L; Mehr, SE; Noorbakhsh, F; Rahimian, R, 2013) |
"Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0." | 1.39 | Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. ( Aminian, A; Dehpour, AR; Ghazi-Khansari, M; Hassanzadeh, G; Javadi, S; Kafami, L; Mehr, SE; Noorbakhsh, F; Rahimian, R, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aminian, A | 1 |
Noorbakhsh, F | 1 |
Ghazi-Khansari, M | 1 |
Kafami, L | 1 |
Javadi, S | 1 |
Hassanzadeh, G | 1 |
Rahimian, R | 1 |
Dehpour, AR | 1 |
Mehr, SE | 1 |
1 other study available for biguanides and Demyelinating Diseases
Article | Year |
---|---|
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Topics: Animals; Biguanides; Cell Proliferation; Demyelinating Diseases; Disease Models, Animal; Dose-Respon | 2013 |